Literature DB >> 12011460

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy.

Antonio Valentin1, Margherita Rosati, Daniel J Patenaude, Angelos Hatzakis, Leondios G Kostrikis, Marios Lazanas, Kathleen M Wyvill, Robert Yarchoan, George N Pavlakis.   

Abstract

We have identified a subset of CD56(+)CD3(-) human natural killer (NK) cells that express CD4 and the HIV coreceptors CCR5 and CXCR4. These cells can be productively infected in vitro by both CCR5- and CXCR4-using molecular clones of HIV-1 in a CD4-dependent manner. Analysis of HIV-infected persons showed that viral DNA is present in purified NK cells, and virus could be rescued from these cells after in vitro cultivation. Longitudinal analysis of the HIV-1 DNA levels in NK cells from patients after 1-2 years of highly active antiretroviral therapy indicated that NK cells remain persistently infected and account for a substantial amount of the viral DNA in peripheral blood mononuclear cells. These results demonstrate that a subset of non-T cells with NK markers are persistently infected and suggest that HIV infection of NK cells is important for virus persistence. The properties of the virus reservoir in these cells should be considered in attempts to further optimize antiretroviral therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011460      PMCID: PMC124520          DOI: 10.1073/pnas.102672999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

Authors:  T W Chun; R T Davey; M Ostrowski; J Shawn Justement; D Engel; J I Mullins; A S Fauci
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression.

Authors:  A Valentin; W Lu; M Rosati; R Schneider; J Albert; A Karlsson; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

3.  In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.

Authors:  J Chehimi; S Bandyopadhyay; K Prakash; B Perussia; N F Hassan; H Kawashima; D Campbell; J Kornbluth; S E Starr
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.

Authors:  G Dornadula; H Zhang; B VanUitert; J Stern; L Livornese; M J Ingerman; J Witek; R J Kedanis; J Natkin; J DeSimone; R J Pomerantz
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

5.  CXCR4 mediates entry and productive infection of syncytia-inducing (X4) HIV-1 strains in primary macrophages.

Authors:  A Valentin; H Trivedi; W Lu; L G Kostrikis; G N Pavlakis
Journal:  Virology       Date:  2000-04-10       Impact factor: 3.616

Review 6.  Pathogenesis of the natural killer cell deficiency in AIDS.

Authors:  M C Sirianni; F Tagliaferri; F Aiuti
Journal:  Immunol Today       Date:  1990-03

7.  Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy.

Authors:  L Zhang; C Chung; B S Hu; T He; Y Guo; A J Kim; E Skulsky; X Jin; A Hurley; B Ramratnam; M Markowitz; D D Ho
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

8.  Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.

Authors:  P M Chaudhary; E B Mechetner; I B Roninson
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

9.  Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

Authors:  M E Sharkey; I Teo; T Greenough; N Sharova; K Luzuriaga; J L Sullivan; R P Bucy; L G Kostrikis; A Haase; C Veryard; R E Davaro; S H Cheeseman; J S Daly; C Bova; R T Ellison; B Mady; K K Lai; G Moyle; M Nelson; B Gazzard; S Shaunak; M Stevenson
Journal:  Nat Med       Date:  2000-01       Impact factor: 87.241

10.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

Authors:  M I Bukrinsky; T L Stanwick; M P Dempsey; M Stevenson
Journal:  Science       Date:  1991-10-18       Impact factor: 63.714

View more
  52 in total

1.  Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence.

Authors:  M C Strain; H F Günthard; D V Havlir; C C Ignacio; D M Smith; A J Leigh-Brown; T R Macaranas; R Y Lam; O A Daly; M Fischer; M Opravil; H Levine; L Bacheler; C A Spina; D D Richman; J K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

Review 2.  The innate immune system and HIV pathogenesis.

Authors:  Karla A Eger; Derya Unutmaz
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

Review 3.  Role of natural killer cells in HIV pathogenesis.

Authors:  Jeffrey Ward; Edward Barker
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

4.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

5.  High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression.

Authors:  Fareed Ahmad; Henoch S Hong; Marc Jäckel; Alexandra Jablonka; I-Na Lu; Nupur Bhatnagar; Johanna M Eberhard; Benjamin A Bollmann; Matthias Ballmaier; Margot Zielinska-Skowronek; Reinhold E Schmidt; Dirk Meyer-Olson
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

6.  Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 7.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

8.  Identification of a potential pharmacological sanctuary for HIV type 1 in a fraction of CD4(+) primary cells.

Authors:  Antonio Valentin; Matthew Morrow; Richard H Poirier; Karen Aleman; Richard Little; Robert Yarchoan; George N Pavlakis
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

9.  Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.

Authors:  Barbara Ensoli; Stefania Bellino; Antonella Tripiciano; Olimpia Longo; Vittorio Francavilla; Simone Marcotullio; Aurelio Cafaro; Orietta Picconi; Giovanni Paniccia; Arianna Scoglio; Angela Arancio; Cristina Ariola; Maria J Ruiz Alvarez; Massimo Campagna; Donato Scaramuzzi; Cristina Iori; Roberto Esposito; Cristina Mussini; Florio Ghinelli; Laura Sighinolfi; Guido Palamara; Alessandra Latini; Gioacchino Angarano; Nicoletta Ladisa; Fabrizio Soscia; Vito S Mercurio; Adriano Lazzarin; Giuseppe Tambussi; Raffaele Visintini; Francesco Mazzotta; Massimo Di Pietro; Massimo Galli; Stefano Rusconi; Giampiero Carosi; Carlo Torti; Giovanni Di Perri; Stefano Bonora; Fabrizio Ensoli; Enrico Garaci
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

10.  Failure to detect active virus replication in mast cells at various tissue sites of HIV patients by immunohistochemistry.

Authors:  Ann Marie Nelson; Aaron Auerbach; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2009-09-22       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.